Concepedia

Miki Terasaka

MT

2

Publications

152

Citations

2

H-Index

2018

Active since

Affiliations

Taiho Pharmaceutical (Japan)(Current)

Miki Terasaka is an author at Taiho Pharmaceutical (Japan).

Publications per year

2018–2019

2

Publications

2

TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations

Shinichi Hasako, Miki Terasaka, Naomi Abe et al. · Molecular Cancer Therapeutics · 2018 · 82 citations

TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant <i>EGFR</i> Mutations

Hibiki Udagawa, Shinichi Hasako, Akihiro Ohashi et al. · Molecular Cancer Research · 2019 · 70 citations · Full text

Rows per page

1–2 of 2